Back
Regeneron Pharmaceuticals Vs. AbbVie Industry Stock Comparison
Buy
70
REGN
Regeneron Pharmaceuticals
Last Price:
972.84
Seasonality Move:
8.27%
Buy
57
ABBV
AbbVie
Last Price:
160.75
Seasonality Move:
-0.31%
Buy
70
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $973.80. The Score for REGN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $160.75. The Score for ABBV is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $973.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
ABBV Stock Price Chart
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.96 | Buy |
| Relative Strength Index (14 RSI): | 65.57 | Buy |
| Chaikin Money Flow: | 20429 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (891.81 - 949.93) | Buy |
| Bollinger Bands (100): | (899.01 - 970.87) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.76 | Sell |
| Relative Strength Index (14 RSI): | 38.44 | Sell |
| Chaikin Money Flow: | -905506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.98 - 167.64) | Sell |
| Bollinger Bands (100): | (160.47 - 177.19) | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 952.98 | Buy |
| 20-day SMA: | 918.94 | Buy |
| 50-day SMA: | 942.3 | Buy |
| 200-day SMA: | 874.75 | Buy |
| 8-day EMA: | 952.7 | Buy |
| 20-day EMA: | 936.05 | Buy |
| 50-day EMA: | 934.3 | Buy |
| 200-day EMA: | 882.19 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 161.65 | Sell |
| 20-day SMA: | 163.45 | Sell |
| 50-day SMA: | 171.4 | Sell |
| 200-day SMA: | 157.95 | Buy |
| 8-day EMA: | 161.69 | Sell |
| 20-day EMA: | 164.04 | Sell |
| 50-day EMA: | 167.5 | Sell |
| 200-day EMA: | 160.82 | Sell |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.19 per share, an increase this year of $0.09 per share, and an increase next year of $0.83 per share.
Regeneron Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||